BiomatiQ Group Inaugurated World-Class Manufacturing Facility in Hyderabad on 16th April 2025
BiomatiQ inaugurates world-class life science manufacturing facility in Hyderabad to advance life science manufacturing in India.

(wecompress.com).webp&w=1920&q=75&dpl=dpl_DvHKTkTrxtw9jHK6MpkEndZCmmr3)
Hyderabad, India – April 16, 2025 – BiomatiQ Group is proud to announce the inauguration of its state-of-the-art fully automated manufacturing facility in Hyderabad, a significant milestone in the Group’s mission to build a self-reliant and innovation-led life science business eco-system in India.
The facility was inaugurated on 16th April 2025 in the presence of distinguished guests, partners, and industry stakeholders. The grand ceremony featured a ribbon-cutting by Sri K.V.G.K. Raju, an esteemed figure, followed by the ceremonial lighting of the diya by Sri K.V.G.K. Raju, Mr. Pavan Kumar, Mr. Natarajan, Mr. Jean-Francois Jochim (Biokar Diagnostics), Mr. Rakesh Aggarwal, and Mr. Omkaranath B. This new unit reinforces BiomatiQ’s commitment to the Make in India initiative by offering locally manufactured, globally benchmarked products for the pharmaceutical, biotechnology, food testing, and research sectors.
Strategically designed to support high standards of quality, compliance, and scalability, the new facility will focus on the manufacturing of:
1. Ready-to-Use (RTU) microbiological media plates
2. Laboratory essential products tailored for regulated environments
“This facility represents the next step in our journey of growth and responsibility,” said Omkaranath B, Founder & Managing Director, BiomatiQ Group. He added “We are not just creating infrastructure—we are creating impact. Our goal is to offer world-class products, support innovation in life sciences, and contribute meaningfully to India's scientific and industrial landscape.”
Mr. Rakesh Aggarwal, CEO of BiomatiQ Group, added, “The commissioning of this facility is more than an expansion—it’s a commitment. A commitment to quality, to our partners, and to the advancement of scientific manufacturing in India. We are proud to take this step forward and strengthen our capabilities to serve both domestic and global markets.”
Facility Highlights:
1. Fully automated Grade A aseptic filling line for high-precision, contamination-free RTU media
2. GMP-compliant manufacturing zones with ISO-certified operations
3. In-house microbiology and quality control laboratories, designed to support 21 CFR Part 11 compliance
4. Scalable and sustainable production infrastructure with a focus on data-driven operations and minimal human intervention
5. The production process includes automated plate loading, gamma label application, triple wrapping, batch incubation, and 100% visual inspection, ensuring consistent product quality and regulatory adherence.
The inauguration also showcased BiomatiQ’s broader vision—to be a comprehensive life science partner through its integrated offerings that include:
1. Microbial testing services via a dedicated contract laboratory with Rapid Microbiological Methods (RMM)
2. Technical training and hands-on experience centre to empower the next generation of life science professionals
About BiomatiQ Group
BiomatiQ Group is a dynamic and fast-growing life sciences organization focused on delivering excellence across Products, manufacturing, services, and education. With a mission to build India’s most trusted life science business eco-system, BiomatiQ continues to expand its footprint with innovation, reliability, and purpose at its core.
Simantini Singh Deo works on the latest and trending news happening daily in the pharma world.
Más de Pharma News
Todos los artículos →
Medicus Pharma presenta al FDA el protocolo combinado de fase 2b/3 para Teverelix

Fresenius Kabi recibe una carta de advertencia de la FDA tras fallos en la investigación del procesamiento aséptico en la planta de Melrose Park

Discussion